Beyond the Stereotype: What the Data Really Say About Eating Disorders

Eating Disorders Awareness Week 2026 | Calai Health

Eating disorders are among the most misunderstood, misrepresented, and under-resourced illnesses in all of psychiatry. The image most people carry when they hear the term eating disorder has historically been a young, thin, white woman. But that conventional image is not even close to the full picture, and it is a dangerous one. It has shaped who gets diagnosed, who gets treated, and whose suffering gets taken seriously.

As I reflect during Eating Disorders Awareness Week, I want to offer something more than awareness. I want to offer accuracy. What follows is a frank look at the data behind these illnesses: their reach, their lethality, the populations most harmed by the research and treatment gap, the neurobiology that underlies them, and the evidence-based treatments that are changing lives.

TL;DR — Key Takeaways

Short on time? Here is what this post covers and why it matters.

• Eating disorders are deadly and massively undertreated. They carry the second highest mortality rate of any psychiatric illness, affect an estimated 28.8 million Americans, yet more than 70% of those who need treatment will never receive it. Research funding is just 73¢ per affected person per year.

• The "young white woman" stereotype is costing lives. BIPOC individuals are equally likely to develop eating disorders but are half as likely to be diagnosed or treated. LGBTQ+ youth face rates 3–6 times higher than their cisgender heterosexual peers. Men, older adults, and menopausal women are systematically overlooked.

• Eating disorders are brain-based, genetically driven illnesses. Heritability ranges from 58–83% depending on diagnosis. Disordered eating is not caused by vanity or bad parenting. Certain temperament traits, neurobiological differences, and metabolic factors precede and outlast the eating disorder.

• DBT and RO-DBT are among the most promising treatments available — and they work differently. DBT targets emotional undercontrol (e.g., binge-eating and purging presentations). RO-DBT targets maladaptive overcontrol (e.g., predominantly restrictive presentations). Matching treatment to neurobiological profile is a critical driver of outcomes.

The Scope and Severity: Mortality and Morbidity

Eating disorders are not a phase, a lifestyle choice, or an issue of vanity. They are serious, brain-based illnesses with some of the highest mortality rates of any psychiatric condition.

An estimated 28.8 million Americans will have an eating disorder in their lifetime. That is roughly 9% of the U.S. population.

Despite those numbers, more than 70% of those struggling will never receive the treatment they need. Eating disorders are chronically underfunded: research receives just 73¢ per person affected annually, totaling around $21 million per year. For comparison, schizophrenia receives approximately $81 per person.

The mortality picture is sobering. Eating disorders have the second highest mortality rate of any psychiatric illness, behind only opioid addiction. Anorexia nervosa (AN) carries the highest case mortality rate of any mental health condition.

Consider:

• Mortality rates for people with AN are 5.86 times higher than the general population. In young people, this rises to 12 times higher compared to peers of the same age.

• Up to 20% of people with chronic, untreated AN will die as a result of the illness.

• Suicide is the second most common cause of death among those diagnosed with AN. Cardiac arrest is the first.

• Bulimia nervosa (BN) carries a standardized mortality ratio of 1.93, and approximately 3.9% of individuals with BN die from complications.

• Up to 90% of people with AN develop osteopenia, osteoporosis, and bone loss during critical developmental years, which may never fully reverse.

• About 20% of people with AN develop dangerous, potentially fatal cardiac arrhythmias.

The global prevalence of eating disorders has more than doubled since the year 2000, rising from 3.4% to 7.8% worldwide. The COVID-19 pandemic accelerated this trajectory sharply: emergency department visits for eating disorders among adolescents rose 107.4% between 2018 and 2022.

Fewer than 6% of people with an eating disorder are medically underweight. People in larger bodies are at the highest risk of developing an eating disorder in their lifetime, yet they are diagnosed at half the rate of those at lower weights.

Further Reading

van Hoeken & Hoek (2020). Review of the burden of eating disorders: mortality, disability, costs, quality of life, and family burden. Current Opinion in Psychiatry, 33(6), 521–527.

Project HEAL. Eating Disorder Statistics. Retrieved from theprojectheal.org/eating-disorder-statistics

Who Is Being Left Behind: Underserved and Under-Researched Populations

One of the most important things researchers and clinicians now know is that the eating disorder research base was built almost entirely on studies of young, white, cisgender, heterosexual, thin women. The implications of this narrow sample are profound: the tools used to screen for eating disorders, the symptoms considered diagnostic, and the treatments tested have all been calibrated to a population that does not represent the full picture of who develops these disorders.

BIPOC Individuals

Studies consistently show that BIPOC persons develop eating disorders at rates comparable to their white peers. The difference is in what happens next. BIPOC individuals are half as likely to be diagnosed or receive treatment for an eating disorder as their white counterparts. This is not because these individuals are less affected, rather, it is due to systemic bias in clinical practice and cultural shortcomings in screening tools.

Black teenagers are 50% more likely than white teenagers to exhibit behaviors like binge eating and purging. Yet clinicians are significantly less likely to assess or refer Black patients for eating disorder evaluation.

Hispanic and Latine individuals show disproportionately elevated rates of BN. Asian American college students report higher levels of body dissatisfaction than their non-Asian BIPOC peers. Native and Indigenous communities face compounding risk factors including epigenetic trauma, food insecurity, and colonization of food culture, yet are among the most underrepresented groups in eating disorder research.

Unique risk factors for BIPOC communities include experiences of racism, xenophobia, microaggressions, internalized Eurocentric beauty standards, and a sense of not belonging within both dominant culture and within eating disorder treatment spaces, which are overwhelmingly white. As of recent estimates, there are fewer than 150 BIPOC or LGBTQ+ eating disorder specialists in the entire United States, representing approximately 5% of the field.

LGBTQ+ and Gender-Nonconforming Individuals

Sexual and gender minority individuals face some of the highest eating disorder rates of any population, driven by minority stress, body image pressures specific to LGBTQ+ culture, internalized homophobia or transphobia, gender dysphoria, and trauma. Overall, LGBTQ+ youth are three times more likely to have an eating disorder compared to their heterosexual cisgender peers.

Transgender college students are diagnosed with eating disorders at four times the rate of their cisgender classmates. Transgender boys/men and non-binary individuals assigned female at birth report the highest rates of any subgroup, at 12% and 11% respectively.

Gay and bisexual males are six times more likely to have an eating disorder than their heterosexual peers. About one in three sexual minority teenagers report engaging in dangerous weight control behaviors within the past month.

LGBTQ+ youth diagnosed with an eating disorder are four times more likely to have attempted suicide in the past year compared to those without an eating disorder diagnosis. Among transgender college students with eating disorders, approximately 75% have attempted suicide.

Body dissatisfaction is near-universal in LGBTQ+ youth populations: 87% of LGBTQ+ youth report being dissatisfied with their body. Despite these alarming statistics, LGBTQ+-affirming eating disorder care remains rare, and most treatment programs were not designed with the specific experiences of gender and sexual minority people in mind.

Men with Eating Disorders

Eating disorders in men are systematically undercounted and underdiagnosed. Cultural narratives around masculinity create barriers to help-seeking at every level: men are less likely to recognize eating disorder symptoms in themselves, less likely to be asked about them by clinicians, and less likely to be referred for treatment even when symptomatic.

Estimates of eating disorder prevalence in men range from 0.74% to 2.2%, but these figures likely represent significant underreporting. More recent research suggests men may account for 25% of eating disorder cases, compared to the commonly cited 10%, though the field still lacks the large-scale male-inclusive studies needed to establish firm prevalence data.

Men with eating disorders often present uniquely. Muscle dysmorphia, a preoccupation with being insufficiently muscular, is a common presentation that rarely gets classified or treated within an eating disorder framework. The use of anabolic steroids, laxatives, and extreme restriction in service of body composition goals in men often goes unaddressed in clinical settings.

Older Adults and Menopausal Women

Perhaps the most invisible population in eating disorder research and treatment is middle-aged and older adults. The longstanding assumption that eating disorders are diseases of youth has left a significant and growing group without adequate recognition or care.

15% of women will experience an eating disorder by their 40s or 50s, yet less than a third of them will ever receive treatment.

Eating disorders in midlife and beyond often emerge or re-emerge in the context of menopause. The hormonal shifts of perimenopause and menopause alter body composition, drive weight gain in the midsection, and intensify cultural pressure on women to maintain a youthful appearance. For women with a history of eating disorders, this period can trigger relapse. For others, it may present a first onset.

Menopausal women with eating disorders face a compounding crisis: the physical consequences of disordered eating interact with menopausal symptoms to create serious medical risk, including accelerated bone density loss, cardiovascular stress, and metabolic disruption. Yet most eating disorder treatment programs are designed for teens and young adults, leaving this population without developmentally appropriate care.

Beyond menopause, eating disorders across the lifespan in older adults, including AN in people in their 60s, 70s, and beyond, are increasingly documented but remain dramatically underrepresented in clinical training, research, and practice guidelines.

Further Reading

Parker & Harriger (2020). Eating disorders and disordered eating behaviors in the LGBT population: a review of the literature. Journal of Eating Disorders, 8, 51.

ANAD (2024). Eating Disorder Statistics. Retrieved from anad.org/learning-library/eating-disorder-statistic/ anad.org/eating-disorder-statistic.

Wired This Way: The Neurobiology and Temperament of Eating Disorders

One of the most important paradigm shifts in eating disorder treatment and research over the past two decades is the recognition that these are fundamentally brain-based illnesses. Disordered eating is rarely the product of vanity, weakness, or poor parenting. Eating disorders emerge from a complex interaction of genetic predisposition, neurobiological architecture, temperament, and environmental triggers.

The Genetic Basis

The heritability of eating disorders is substantial and well-established across multiple large-scale twin and family studies:

•  AN: 58–74% heritable

•  BN: 59–83% heritable

•  Binge eating disorder (BED): 41–57% heritable

•  Avoidant Restrictive Food Intake Disorder (ARFID): ~ 79% heritable

First-degree relatives of individuals with AN are 11 times more likely to develop the illness than relatives of non-AN individuals. Genome-wide association studies (GWAS) conducted by the Eating Disorders Working Group of the Psychiatric Genomics Consortium have identified specific genetic loci associated with AN, including genes expressed in brain tissues such as medium spiny neurons and hippocampal pyramidal cells. These are the same cell types implicated in reward processing, habit formation, and emotional memory.

Importantly, genome-wide analyses have established that AN is not only a psychiatric disorder but a metabo-psychiatric one, meaning it has significant genetic overlap with metabolic traits. AN shares genetic architecture with body mass index, insulin sensitivity, and lipid metabolism. This has profound implications for treatment, suggesting that for some, restriction may be partially driven by metabolic processes that feel intrinsically rewarding in ways that differ from the general population.

Temperament and the Overcontrolled Brain

Research consistently identifies a cluster of temperament traits that precede eating disorder onset and persist even after recovery: perfectionism, rigid/inflexible thinking, harm avoidance, high sensitivity to threat, emotional inhibition, and weak central coherence (a bias towards detail-focused processing at the expense of the broader picture).

These traits are heritable and appear to represent underlying neurobiological predispositions rather than psychological defenses. Neuroimaging studies have documented structural and functional differences in the frontal cortex, insula, and basal ganglia of individuals with eating disorders, many of which persist after weight restoration. This suggests that at least part of what clinicians observe behaviorally reflects stable differences in brain architecture, not simply the effects of malnutrition.

Individuals with AN show consistent cognitive patterns including reduced set-shifting (cognitive flexibility), impaired decision-making under uncertainty, heightened sensitivity to punishment, and a diminished response to reward — patterns that characterize what researchers call "maladaptive overcontrol."

The concept of overcontrol is central to understanding a significant subset of eating disorders, particularly restrictive presentations. Overcontrolled individuals use rigid self-regulation, emotional suppression, and rule-governed behavior to manage perceived threats. While these traits may be adaptive in some situations, they can be life-threatening among those with certain biological predispositions and environmental stressors.

For individuals with binge-purge presentations, the neurobiological picture often involves impulsivity, emotion dysregulation, and heightened sensitivity to both reward and punishment. This unique neurobiological foundation may require addressing distress tolerance and emotion regulation alongside eating disorder specific care.

Puberty, Hormones, and Epigenetics

Interestingly, heritability estimates for eating disorders in girls are near zero before puberty and rise steeply afterward, reaching approximately 50% in adulthood. This suggests that ovarian hormones may act as an activator in those with a pre-existing genetic risk. This points to the importance of prevention programs and early intervention. For boys and men, heritability appears more stable across developmental stages at approximately 50%.

Epigenetic research adds another layer: in individuals with chronic AN, sustained restriction produces changes in gene expression through DNA methylation, essentially locking in biological patterns that make the illness increasingly entrenched over time. This is one reason why early intervention dramatically improves outcomes: the window for interrupting these epigenetic changes might close with illness duration.

Further Reading

Bulik et al. (2022). Genetics and neurobiology of eating disorders. Nature Neuroscience, 25, 543–554.

What Works: DBT, RO-DBT, and the Promise of Targeted Treatment

The recognition that eating disorders arise from neurobiologically distinct presentations has transformed the treatment landscape. Two approaches in particular have emerged as especially promising for populations that have historically been difficult to treat: Dialectical Behavior Therapy (DBT) and Radically Open DBT (RO-DBT).

Dialectical Behavior Therapy

Originally developed by Dr. Marsha Linehan for suicidal/parasuicidal behavior and borderline personality disorder, DBT has been adapted for eating disorders over the past two decades. Its core emphasis on distress tolerance, emotion regulation, mindfulness, and interpersonal effectiveness maps onto many skill deficits common in those who present with binge-purge symptoms.

DBT targets the undercontrolled end of the temperament spectrum: individuals who experience intense, rapidly shifting emotions, who use eating disorder behaviors as a means of emotional escape or regulation, and for whom impulsivity plays a significant role. The evidence base for DBT in BN and BED is particularly strong. Research shows that DBT significantly reduces binging and purging frequency, improves emotion regulation, and reduces self-harm and suicidal behaviors. Studies using DBT for eating disorders report meaningful gains even in those with histories of 4 to 22 years of illness and multiple prior treatment failures.

Radically Open Dialectical Behavior Therapy

RO-DBT was developed specifically for disorders of overcontrol, and AN is among its primary target conditions. Where standard DBT addresses emotion undercontrol, RO-DBT addresses the opposite: the pain of excessive self-control, emotional inhibition, and the profound social disconnection that is tied to reticence and rigidity.

RO-DBT proposes that the core problem in overcontrolled presentations is not poor impulse control but emotional loneliness: a pattern of masked or suppressed emotion expression that makes genuine social connection challenging, which in turn reinforces rigid self-reliance and rule-governed behavior. Treatment focuses on increasing openness, flexible responding, and the capacity for genuine social engagement.

In a feasibility study of RO-DBT for inpatient AN, 47 severely underweight individuals (mean BMI of 14.43) demonstrated significant improvements in weight gain, reductions in eating disorder psychopathology, and improved quality of life over approximately 22 weeks of treatment.

A 2025 outpatient study of 23 individuals with AN who underwent a 32-week standard RO-DBT intervention had an 83% retention rate, high treatment satisfaction, a reduction in eating disorder psychopathology, and significant BMI increases. A separate single-case experimental design study across 13 adult outpatients with AN found that 100% of treatment completers achieved full remission.

The emerging evidence suggests a clinically meaningful differentiation: RO-DBT performs best for restrictive, overcontrolled presentations (primarily AN and ARFID), while standard DBT is ideal for emotionally dysregulated presentations with binging and/or purging (BN, BED, and mixed presentations with significant impulsivity). In the DBT world, matching patients to the treatment aligned with their neurobiological and temperament profile is increasingly understood as a key driver of outcomes.

What This Means for the Future of Treatment

The convergence of neurobiology, temperament research, and evidence-based treatment is creating a more precise map of eating disorder care. Staging models based on biology, not just symptom severity, are on the horizon. Approaches targeting the metabo-psychiatric underpinnings of AN are under investigation. And the recognition that one treatment cannot possibly fit all presentations is reshaping how clinicians train and how treatment programs are designed.

At Calai Health, this is the framework from which we build. DBT and RO-DBT skills are not generic coping tools. They are precision instruments calibrated to specific neurobiological profiles and the ability to meet each person where they are.

Further Reading

Hatoum & Burton (2024). Applications and efficacy of radically open dialectical behavior therapy (RO-DBT): A systematic review of the literature. Journal of Clinical Psychology, 80(11), 2283–2302.

Ben-Porath et al. (2020). Dialectical behavior therapy: an update and review of the existing treatment models adapted for adults with eating disorders. Eating Disorders, 28(2), 101–121.

A Different Kind of Awareness

Awareness, at its best, does more than illuminate. It disrupts. It challenges comfortable assumptions that permit complacency.

Eating disorders are not a demographic. They are not a personality type. They are not a choice or a symptom solely of culture. They are biologically based, genetically influenced, neurobiologically distinct illnesses that can affect anyone, including those in bodies and genders you may not assume, with skin at every hue, and at any age or stage.

The person in a larger body who has been stigmatized and told to "just eat less." The middle-aged man whose restriction gets called discipline. The Black teenager who’s purging never prompts a referral. The transgender adolescent for whom every treatment program feels like it just does not fit. The 50-year-old woman whose menopause-related relapse goes unrecognized as a relapse at all.

These are not edge cases. They are the majority of people living with eating disorders.

Eating Disorders Awareness Week has ended.  The need for better science, better access, and better care has not.